Dofetilide

多菲菜德

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDofetilide
Drug Alias Name多菲利特dofetilidadofetilidum多非利特Tikosyn +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersVoltage-gated potassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel
Therapy Area/IndicationsAtrial FlutterAtrial Fibrillation
Global Approved IndicationsAtrial FlutterAtrial Fibrillation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1999/10/01
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesPfizer Ltd
Active IndicationsAtrial FlutterAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeC01BD04
Related LinksWikipediaDrugBankKEGG